Retraction Note: HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma.

MLA

Lv, Xiupeng, et al. “Retraction Note: HOXD9 Promotes Epithelial–mesenchymal Transition and Cancer Metastasis by ZEB1 Regulation in Hepatocellular Carcinoma.” Journal of Experimental & Clinical Cancer Research (17569966), vol. 43, no. 1, Aug. 2024, p. 1. EBSCOhost, https://doi.org/10.1186/s13046-024-03171-z.

APA

Lv, X., Li, L., Lv, L., Qu, X., Jin, S., Li, K., Deng, X., Cheng, L., He, H., & Dong, L. (2024). Retraction Note: HOXD9 promotes epithelial–mesenchymal transition and cancer metastasis by ZEB1 regulation in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research (17569966), 43(1), 1. https://doi.org/10.1186/s13046-024-03171-z

Chicago

Lv, Xiupeng, Linlin Li, Li Lv, Xiaotong Qu, Shi Jin, Kejun Li, Xiaoqin Deng, Lei Cheng, Hui He, and Lei Dong. 2024. “Retraction Note: HOXD9 Promotes Epithelial–mesenchymal Transition and Cancer Metastasis by ZEB1 Regulation in Hepatocellular Carcinoma.” Journal of Experimental & Clinical Cancer Research (17569966) 43 (1): 1. doi:10.1186/s13046-024-03171-z.